FUJIFILM Holdings reports strong first quarter revenue, eyes spin-off of business division

FUJIFILM Holdings Corp. reported strong first-quarter revenue growth for fiscal 2027, with its Imaging segment emerging as one of the company’s key growth drivers. For the three months ended June 30, 2026, Fujifilm posted consolidated revenue of ¥826.5 billion, up 10.3% from ¥749.5 billion a year earlier. Profitability, however, declined sharply: Operating income fell 32% to ¥51.2 billion, while net income attributable to Fujifilm Holdings dropped 30.4% to ¥37.4 billion. The company attributed the earnings decline primarily to higher fixed costs in its Bio CDMO operation, restructuring-related costs in Business Innovation (see announcement below) and rising raw-material costs.

Specifically, rising memory costs are a problem. Fujifilm expects rising semiconductor memory prices to weigh on companywide profitability, although it did not specify how much of that impact will fall on its camera and imaging operations. The company said stronger Electronics sales and gains from the proposed sale of non-core Business Innovation assets would be offset by two factors: delayed profitability in the Bio CDMO business and the impact of rising semiconductor memory prices.

Imaging provided a significantly brighter picture. Segment revenue climbed 16.2% to ¥168.8 billion from ¥145.3 billion, representing about 20% of Fujifilm’s consolidated revenue. Imaging operating income increased 3.9% to ¥43.4 billion.

Consumer Imaging benefited from continued expansion of the instax instant photography business. Fujifilm reported strong demand for higher-priced products, including the instax mini Evo and instax WIDE 400. Importantly for the photo output market, instax film sales also increased as Fujifilm expanded production capacity. The company also launched the entry-level instax mini 13 in April, reporting a positive global reception.

Professional Imaging also recorded higher revenue, driven by expanding digital camera sales, particularly in Asia. Fujifilm cited strong performance from the X-E5 and X-T30 III, along with continued demand for the X100VI. The company is broadening its camera portfolio with products including the GFX100RF, X half and GFX ETERNA 55. Imaging generated ¥43.4 billion of operating income during the quarter—more than 80% of Fujifilm’s consolidated operating income before corporate expenses and losses in other segments are considered.

For the full fiscal year ending March 31, 2027, Fujifilm raised its consolidated revenue forecast from ¥3.47 trillion to ¥3.56 trillion, although it maintained its ¥365 billion operating income forecast. The revision primarily reflects stronger Electronics sales and currency movements rather than a change in the Imaging outlook.

In other news, FUJIFILM Holdings Corp. also announced that it has begun the assessment of a partial spin-off of its Business Innovation business, premised on the listing of the shares of FUJIFILM Business Innovation Corp., a wholly-owned subsidiary of FUJIFILM Holdings Corporation, as one of the key strategic options aimed at sustainable growth of the Business Innovation business. The division was started as Fuji Xerox, a joint venture between Rank Xerox Ltd. (whose name was changed to Xerox on Oct. 31, 1997) and Fuji Photo Film Co., Ltd. It changed the corporate name to FUJIFILM Business Innovation in April, 2021, following the failed merger of Fuji Xerox and Xerox.

As the Business Innovation business accelerates its shift toward a solutions-driven model and enters a new phase of growth, the Company recognizes the need of the Business Innovation business for a more agile operating framework to effectively execute strategic initiatives and drive further business expansion. Accordingly, the company said it has commenced an assessment of a partial spin-off of the Business Innovation Business, while retaining a less than 20% stake in the business, enabling the business to continue utilizing the Fujifilm brand, including its trade name, and generating synergies with companies in the Fujifilm Group. The assessment and spin-off could take two to three years. Items to be assessed will include the selection of the listing market for the shares of FUJIFILM Business Innovation Corporation and the possibility of satisfying qualifications for tax-free treatment.